New York-based Nolla Health has launched a pilot program in Utah, becoming the first U.S. company authorized to use artificial intelligence for issuing initial acne treatment prescriptions.
Key Points
- The Nolla Derm application allows Utah residents aged 18 and older to receive personalized acne treatment plans and prescriptions after a 15-minute digital intake process.
- The program is authorized by the Utah Office of Artificial Intelligence Policy and will roll out in three distinct stages with varying levels of physician oversight.
- Safety protocols require a 95% agreement rate between the AI and human physicians, alongside zero serious adverse events, to progress through the pilot stages.
- Patients can access the service for $4.99 per month, bypassing traditional dermatologist office visits and associated wait times.
- The company selected acne treatment for the pilot due to the condition's low-risk profile and extensive clinical evidence.